Advisors Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$228K	Buy	295 +10	+4%	+$7.66K	﹤0.01%	528
2025 Q4	$220K	Buy	+285	New	+$194K	﹤0.01%	540
2025 Q2	–	Sell	-921	Closed	-$584K	–	532
2025 Q1	$584K	Sell	921 -801	-47%	-$551K	0.01%	341
2024 Q4	$1.23M	Sell	1,722 -35	-2%	-$29.4K	0.02%	281
2024 Q3	$1.85M	Buy	1,757 +174	+11%	+$194K	0.03%	252
2024 Q2	$1.67M	Buy	1,583 +8	+0.5%	+$7.75K	0.03%	260
2024 Q1	$1.52M	Buy	1,575 +2	+0.1%	+$1.9K	0.03%	263
2023 Q4	$1.38M	Buy	1,573 +1,181	+301%	+$973K	0.03%	269
2023 Q3	$323K	Sell	392 -3	-0.8%	-$2.36K	0.01%	348
2023 Q2	$284K	Buy	395 +14	+4%	+$10.8K	0.01%	373
2023 Q1	$313K	Buy	381 +4	+1%	+$3.02K	0.01%	365
2022 Q4	$272K	Sell	377 -3	-0.8%	-$2.21K	0.01%	389
2022 Q3	$282K	Buy	380 +7	+2%	+$4.41K	0.01%	396
2022 Q2	$220K	Sell	373 -2	-0.5%	-$1.3K	0.01%	407
2022 Q1	$262K	Buy	+375	New	+$237K	0.01%	386